The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

Provenge (sipuleucel-T) is created by exposing the immune cells of someone with prostate cancer to a protein that “teaches” ...

The overall survival observed across the three groups was 19 months, representing, “to our knowledge, the longest overall ...

In Louisiana and across the country, pancreatic cancer continues to be one of the most aggressive and deadly forms of the ...

Funds raised by campaign will support CancerCare Manitoba Foundation and Camp Quality Manitoba ...

A powerful, three-drug therapy for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...

According to a Boston University study head and neck cancer (HNC) trials have been less diverse between 2000 and 2023.

The University of Birmingham’s Cancer Research UK Clinical Trials Unit is leading a new trial to improve outcomes for ...

As more young people are diagnosed with breast cancer, they worry about returning stage 4, metastatic breast cancer. Experts ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each ...

Boston is a city recognized worldwide for its cutting-edge advancements in science and medicine, especially in the field of ...